{"id":"e47a78dc-c42c-5fed-a305-980c6ac44af9","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:oral-nattokinase-delays-ferric-chloride-arterial-occlusion","predicate":"delays","statement":"Oral nattokinase for one week delayed ferric-chloride-induced carotid occlusion dose-dependently, doubling occlusion time at 160 mg/kg and fully preventing occlusion at 500 mg/kg.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"c26adc7d-6829-5c2c-839d-f2e9d64ccd89","mechanism_event_label":"Oral nattokinase for one week delayed ferric-chloride-induced carotid occlusion dose-dependently, doubling occlusion time at 160 mg/kg and fully preventing occlusion at 500 mg/kg.","subject":{"id":"6b03a125-209a-5060-8b35-ec9e0e54033c","slug":"nattokinase","display_name":"Nattokinase / subtilisin NAT","entity_type_key":"peptide"},"object":{"id":"36a282f4-d3f7-58de-bd77-8d841ffcd328","slug":"rat-arterial-occlusion-time","display_name":"Time to arterial occlusion after ferric-chloride injury in rat carotid artery","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"c26adc7d-6829-5c2c-839d-f2e9d64ccd89","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:oral-nattokinase-delays-ferric-chloride-arterial-occlusion-event","event_type":"observed_intervention","label":"Oral nattokinase for one week delayed ferric-chloride-induced carotid occlusion dose-dependently, doubling occlusion time at 160 mg/kg and fully preventing occlusion at 500 mg/kg.","description":"Carotid artery, 35% FeCl3 injury, laser Doppler flow","status":"provisional","compartment":null,"participants":[{"entity":{"id":"6b03a125-209a-5060-8b35-ec9e0e54033c","slug":"nattokinase","display_name":"Nattokinase / subtilisin NAT","entity_type_key":"peptide"},"role":"acting component","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"36a282f4-d3f7-58de-bd77-8d841ffcd328","slug":"rat-arterial-occlusion-time","display_name":"Time to arterial occlusion after ferric-chloride injury in rat carotid artery","entity_type_key":"cellular_process"},"role":"component the finding is about","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"duration","value_text":"1 week of pre-treatment","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Nattokinase 160 or 500 mg/kg","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"An oral in vivo effect, which makes it one of the few records here that clears the absorption question by outcome rather than by measurement. It does not identify what crossed the gut. The test article is described only as nattokinase extracted from fermented soybean.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Oral nattokinase for one week delayed ferric-chloride-induced carotid occlusion dose-dependently, doubling occlusion time at 160 mg/kg and fully preventing occlusion at 500 mg/kg.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation. (2013) https://pubmed.ncbi.nlm.nih.gov/24396387/ DOI: 10.5625/lar.2013.29.4.221","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vivo, oral","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Carotid artery, 35% FeCl3 injury, laser Doppler flow","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"96853538-b112-510d-a76b-d7c093c9609c","evidence_kind":"source_excerpt","locator":"Lines 301-301","start_line":301,"end_line":301,"excerpt":"Oral nattokinase for one week delayed ferric-chloride-induced carotid occlusion dose-dependently, doubling occlusion time at 160 mg/kg and fully preventing occlusion at 500 mg/kg.","model_system":"Rat","directness":"reported_statement","verification_status":"source_derived_draft","notes":"","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"41cb127c-1c23-53aa-b7d0-5ec7f6fa3c99","stable_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","document_type":"imported_text","citation_label":"Original AI-assisted curation built from a supplied entity-first document of 105 entities and 129 claims. Every reference in that document was resolved against live PubMed with its abstract read and its DOI cross-checked on 2026-09-23, and the EFSA novel-food opinion was retrieved and read in full. That check corrected two PMIDs that pointed at unrelated papers, two DOIs, and two papers recorded as carrying no erratum that do carry one; it also reversed three findings the supplied document had stated backwards. Two papers carry a published correction, recorded as such and not as a retraction. Three sources are not indexed in PubMed and are cited by what they have. Laboratory lineages are recorded, so the four papers from one group, the three from another and the two readings of a single applicant dossier cannot be counted as separate lines of support. Study-specific doses, units, populations and limitations retained; activity units are never converted between systems. Not publisher full text.","file_path":"","sha256":"34fc46e0e849d06bfa13cb099a79b50679dd6fd0de8a5a0575326afdde3259c1","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}